The study of DNA methylation in urological cancer: present and future.

[1]  A. M. West,et al.  Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy? , 2013, Urologic oncology.

[2]  D M Berney,et al.  Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer , 2012, Prostate Cancer and Prostatic Diseases.

[3]  J. Serth,et al.  GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression , 2012, BJU international.

[4]  J. Serth,et al.  Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma. , 2012, International journal of oncology.

[5]  J. Schalken,et al.  Molecular diagnosis of prostate cancer: PCA3 and TMPRSS2:ERG gene fusion. , 2012, The Journal of urology.

[6]  Hester F. Lingsma,et al.  A methylation assay for the detection of non‐muscle‐invasive bladder cancer (NMIBC) recurrences in voided urine , 2012, BJU international.

[7]  G. Netto,et al.  DNA methylation profiles delineate epigenetic heterogeneity in seminoma and non-seminoma , 2011, British Journal of Cancer.

[8]  Yixin Wang,et al.  Predicting prostate biopsy result in men with prostate specific antigen 2.0 to 10.0 ng/ml using an investigational prostate cancer methylation assay. , 2011, The Journal of urology.

[9]  Carsten Wiuf,et al.  Comprehensive Genome Methylation Analysis in Bladder Cancer: Identification and Validation of Novel Methylated Genes and Application of These as Urinary Tumor Markers , 2011, Clinical Cancer Research.

[10]  F. Algaba,et al.  Evaluation of the methylation status of tumour suppressor genes for predicting bacillus Calmette-Guérin response in patients with T1G3 high-risk bladder tumours. , 2011, European urology.

[11]  E. Giovannucci,et al.  Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis , 2011, British Journal of Cancer.

[12]  N Clarke,et al.  Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma , 2011, Oncogene.

[13]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[14]  B. Christensen,et al.  Identification of Methylated Genes Associated with Aggressive Bladder Cancer , 2010, PloS one.

[15]  L. de Leval,et al.  Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples. , 2010, European urology.

[16]  S. Freedland,et al.  Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer. , 2010, The Journal of urology.

[17]  P. Albers,et al.  CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer. , 2009, The Journal of urology.

[18]  Q Wang,et al.  Hypomethylation of WNT5A, CRIP1 and S100P in prostate cancer , 2007, Oncogene.

[19]  M. Esteller.  Cancer epigenomics: DNA methylomes and histone-modification maps , 2007, Nature Reviews Genetics.

[20]  Ishtiaq Rehman,et al.  Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage , 2007, Clinical Cancer Research.

[21]  R. Dahiya,et al.  Wnt Antagonist Family Genes as Biomarkers for Diagnosis, Staging, and Prognosis of Renal Cell Carcinoma Using Tumor and Serum DNA , 2006, Clinical Cancer Research.

[22]  R. Uzzo,et al.  Identification of novel target genes by an epigenetic reactivation screen of renal cancer. , 2006, Cancer research.

[23]  J Alfred Witjes,et al.  Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. , 2006, European urology.

[24]  M. Hoque,et al.  Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  P. Carroll,et al.  Multigene Methylation Analysis for Detection and Staging of Prostate Cancer , 2005, Clinical Cancer Research.

[26]  F. Marshall.  Promoter Hypermethylation of Tumor Suppressor Genes in Urine From Kidney Cancer Patients , 2004 .

[27]  A. Balmain,et al.  A Mouse Skin Multistage Carcinogenesis Model Reflects the Aberrant DNA Methylation Patterns of Human Tumors , 2004, Cancer Research.

[28]  Peter A. Jones,et al.  Epigenetics in human disease and prospects for epigenetic therapy , 2004, Nature.

[29]  R. Uzzo,et al.  Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel , 2004, Clinical Cancer Research.

[30]  O. Ogawa,et al.  XISTunmethylated DNA fragments in male-derived plasma as a tumour marker for testicular cancer , 2004, The Lancet.

[31]  J. Cheville,et al.  Solid renal tumors: an analysis of pathological features related to tumor size. , 2003, The Journal of urology.

[32]  P. Babb,et al.  Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons , 2002, BJU international.

[33]  J. Minna,et al.  Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. , 2001, Cancer research.

[34]  J. Herman,et al.  Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[35]  J. Herman,et al.  A gene hypermethylation profile of human cancer. , 2001, Cancer research.

[36]  S. Clark,et al.  Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancer , 1999, Oncogene.

[37]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Herman,et al.  Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[39]  L. E. McDonald,et al.  A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[41]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[42]  A. Feinberg,et al.  The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.

[43]  P. Carroll,et al.  Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.